Can thyroxine halt the progression of peripheral arterial disease?

[1]  L. Hunt,et al.  APOLIPOPROTEINS (a), AI, AND B AND PARENTAL HISTORY IN MEN WITH EARLY ONSET ISCHAEMIC HEART DISEASE , 1988, The Lancet.

[2]  J. Powell,et al.  Raised serum thyrotrophin in women with peripheral arterial disease , 1987, The British journal of surgery.

[3]  L. Hunt,et al.  Serum apolipoproteins AI and B and lipoproteins in middle aged men with and without previous myocardial infarction. , 1986, British heart journal.

[4]  S. Wacholder,et al.  The relation of risk factors to the development of atherosclerosis in saphenous-vein bypass grafts and the progression of disease in the native circulation. A study 10 years after aortocoronary bypass surgery. , 1984, The New England journal of medicine.

[5]  J. Segrest,et al.  Preparative and quantitative isolation of plasma lipoproteins: rapid, single discontinuous density gradient ultracentrifugation in a vertical rotor. , 1980, Journal of lipid research.

[6]  R. Greenhalgh,et al.  Standard exercise test to assess peripheral arterial disease. , 1980, British medical journal.

[7]  G. Cazzolato,et al.  ARE APOLIPOPROTEINS BETTER DISCRIMINATORS THAN LIPIDS FOR ATHEROSCLEROSIS? , 1979, The Lancet.

[8]  D. Appleton,et al.  THE SPECTRUM OF THYROID DISEASE IN A COMMUNITY: THE WHICKHAM SURVEY , 1977, Clinical endocrinology.

[9]  J. Stamler.  The coronary drug project. Findings leading to further modifications of its protocol with respect to dextrothyroxine. The coronary drug project research group. , 1972, JAMA.